Several studies have demonstrated that IgE diversity (recognition of a greater number of epitopes, i.e., “epitope spreading”) is associated with adverse outcomes, that is, more severe allergic reactions or a persistent disease phenotype.14, 15, 24. This evidence concerns the gene IGHE and allergic disease.